wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49787386-1D3D5319-7849-4F89-A064-AF6DDB259274
Q49787386-1D3D5319-7849-4F89-A064-AF6DDB259274
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49787386-1D3D5319-7849-4F89-A064-AF6DDB259274
mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL.
P2860
Q49787386-1D3D5319-7849-4F89-A064-AF6DDB259274
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49787386-1D3D5319-7849-4F89-A064-AF6DDB259274
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3e3842a16cac4f8db348fa5eddd5d437c519e8ba
P2860
TAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemia.